PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Clinical trial NCT03817320 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03817320
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ALL, Childhood Lymphoblastic Lymphoma, Childhood Lymphoblastic Leukemia, Acute, Childhood

Start date: 2019-02-12
Primary completion: 2023-12-03
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.